Company Profile
China Resources Pharmaceutical Group Limited (CR Pharma) (Stock Code: 3320.HK) is a leading integrated pharmaceutical company in China specializing in the manufacturing, distribution, and retail of medicines and nutraceutical products. Since the Company went public, it has introduced a number of important capital market indexes, including Hang Seng Composite LargeCap Index, FTSE Global Large Cap Index, Morgan Stanley Capital International (MSCI) China Index, Hang Seng Stock Connect Hong Kong Index, etc.
We have many subsidiaries, including China Resources Pharmaceutical Commercial Group Co., Ltd. (CR Pharma Comm), China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu, Stock Code: 000999.SZ), China Resources Double-Crane Pharmaceutical Co., Ltd. (CR Double-Crane, Stock Code: 600062.SH), China Resources Jiangzhong Pharmaceutical Group Co., Ltd. (CR Jiangzhong), Dong-E-E-Jiao Pharmaceutical Co., Ltd. (Dong-E-E-Jiao, Stock Code: 000423.SZ), China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), China Resources Biopharmaceutical Co., Ltd., The National Institutes of Pharmaceutical R&D Co., Ltd., China Resources Care Co., Ltd. (CR Care), etc.